Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey
Modern Rheumatology · 2025
DOI: 10.1093/mr/roae102 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Riki Kurokawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Public Health, St. Luke's International University, Tokyo, Japan. Hauptthemen laut MEDLINE: Rheumatic Diseases, COVID-19 Vaccines, COVID-19, Immunization, Secondary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
We studied the current state and factors associated with the acceptance or hesitancy of booster doses of the coronavirus disease 2019 (COVID-19) vaccine among patients with autoimmune and rheumatic diseases (ARDs) in Japan.
Methods
A single-centre cross-sectional survey was conducted among outpatients with ARDs who visited the Immuno-Rheumatology Center at St. Luke’s International Hospital from 1 October 2023 to 30 November 2023. We investigated patient characteristics, COVID-19 vaccination–related status, decision-making preferences, health-related status, and independent factors associated with the acceptance or hesitancy of booster doses of the COVID-19 vaccine.
Results
A total of 241 patients were included in the analyses, and 198 patients (82.2%) received booster doses, while 43 (17.8%) did not. Older age [adjusted odds ratio (aOR) = 0.43, 95% confidence interval (CI): 0.19, 0.95, P = .037], having rheumatoid arthritis (aOR = 0.41, 95% CI: 0.19, 0.92, P = .030), and having a physician recommend receiving the vaccine (aOR = 0.47, 95% CI: 0.23, 0.95, P = .035) were independently associated with receiving booster doses. The main reasons for hesitancy regarding booster doses were concerns about adverse reactions and long-term safety.
Conclusions
Our findings could help physicians counsel patients with ARDs regarding their acceptance of COVID-19 vaccine booster doses to promote appropriate decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Public Health, St. Luke's International University, Tokyo, Japan.
- Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan.
ORCID-Profile: Riki Kurokawa
Zitieren
APA
Kurokawa, R., Ohde, S., Kawaai, S., & Tamaki, H. (2025). Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey. Modern Rheumatology. https://doi.org/10.1093/mr/roae102
Vancouver
Kurokawa R, Ohde S, Kawaai S, Tamaki H. Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey. Modern Rheumatology. 2025. doi:10.1093/mr/roae102
BibTeX
@article{Kurokawa2025,
author = {Kurokawa, Riki and Ohde, Sachiko and Kawaai, Satoshi and Tamaki, Hiromichi},
title = {Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roae102}
}
EUVIMED